Literature DB >> 27878368

[Therapy options for malignant eyelid tumors].

M Weiling1, A Bergua2, F E Kruse2, L Holbach2.   

Abstract

Basal cell carcinomas are the most common malignant tumors of the eyelids. Patient history, clinical symptoms and signs, inspection, palpation and slit-lamp examination usually allow a working diagnosis; however, the clinical diagnosis requires histopathological confirmation and determination of the histopathological type. Squamous cell carcinomas, sebaceous gland carcinomas, melanomas and Merkel cell carcinomas can metastasize usually via the lymph vessels into the regional lymph nodes. Microscopically controlled excision of the primary tumor into healthy tissue is most commonly the first goal. Palpation and ultrasonography of the regional lymph nodes and also computed tomography (CT) with contrast enhancement and magnetic resonance imaging (MRI) for tumors with perineural sheath cell invasion are necessary to define the TNM stage. Non-surgical treatment options are becoming more popular in the further management of malignant eyelid tumors.

Entities:  

Keywords:  Basal cell carcinoma; Excision; Metastasis; Nonsurgical therapy; Squamous cell carcinoma

Mesh:

Substances:

Year:  2016        PMID: 27878368     DOI: 10.1007/s00347-016-0387-5

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  34 in total

1.  [Differential eyelid tumors diagnosis. II].

Authors:  L Holbach; A Jünemann; A Viestenz; A Nasr
Journal:  Ophthalmologe       Date:  2002-06       Impact factor: 1.059

2.  Cutaneous angiosarcoma of the eyelids.

Authors:  R M Conway; T Hammer; A Viestenz; L M Holbach; R M Conway
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

3.  Breast carcinoma metastatic to the eyelid presenting as the first sign of insufficient chemotherapy.

Authors:  F Colombo; C Cursiefen; L M Holbach
Journal:  Ophthalmologica       Date:  2001 Mar-Apr       Impact factor: 3.250

4.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

5.  The use of imiquimod in the treatment of periocular tumours.

Authors:  A H Ross; C T C Kennedy; C Collins; R A Harrad
Journal:  Orbit       Date:  2010-04

Review 6.  [Keratoacanthoma of the eyelid area. Problems and risks in diagnosis and therapy].

Authors:  C R Hintschich; F H Stefani
Journal:  Klin Monbl Augenheilkd       Date:  1997-04       Impact factor: 0.700

7.  Sentinel-node biopsy or nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Robert Elashoff; Richard Essner; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; Edwin C Glass; He-Jing Wang
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

8.  Merkel cell carcinoma of the eyelid: management and prognosis.

Authors:  Helen M Herbert; Michelle T Sun; Dinesh Selva; Bertie Fernando; George M Saleh; Michele Beaconsfield; Richard Collin; Jimmy Uddin; George Meligonis; Brian Leatherbarrow; Sajid Ataullah; Lucianne Irion; Chris J McLean; Shyamala C Huilgol; Garry Davis; Timothy J Sullivan
Journal:  JAMA Ophthalmol       Date:  2014-02       Impact factor: 7.389

9.  Surgery for primary basal cell carcinoma including the eyelid margins with intraoperative frozen section control: comparative interventional study with a minimum clinical follow up of 5 years.

Authors:  R M Conway; S Themel; L M Holbach
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

10.  Thyroid-like ophthalmopathy in a euthyroid patient receiving Ipilimumab.

Authors:  Elizabeth McElnea; Aine Ní Mhéalóid; Sarah Moran; Rory Kelly; Tim Fulcher
Journal:  Orbit       Date:  2014-09-10
View more
  4 in total

Review 1.  [Surgical resection with ophthalmoplastic reconstruction : Gold standard in periocular basal cell carcinoma].

Authors:  A C Rokohl; A Kopecky; Y Guo; V Kakkassery; J M Mor; N Loreck; K R Koch; L M Heindl
Journal:  Ophthalmologe       Date:  2020-02       Impact factor: 1.059

2.  [Young male patient with unusual space-occupying lesion of the lower eyelid].

Authors:  Alexander C Rokohl; Heike Löser; Joel M Mor; Niklas Loreck; Konrad R Koch; Ludwig M Heindl
Journal:  Ophthalmologe       Date:  2020-01       Impact factor: 1.059

3.  [Hordeolum and chalazion : (Differential) diagnosis and treatment].

Authors:  Christiane Loth; Christina V Miller; Christos Haritoglou; Eli Sa Beth M Messmer
Journal:  Ophthalmologe       Date:  2021-08-11       Impact factor: 1.059

4.  Case report repairing orbital skin defects using composite flaps after giant eyelid-derived tumor excision and orbital exenteration.

Authors:  Bin Fan; Jian-Ju Liu; Bei-Fen Wang; Ying-Jian Sun; Guang-Yu Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.